Using state-of-the-art technology, they seek to unraveled the genome of patients with chronic lymphocytic leukemia and give new key insights into the disease.
The study, which is a scientific milestone in this country, identifies four genes whose mutation causes this kind of leukemia.
Read the news
Read the news
The agreements drawn up by IRB Barcelona with various I+D programmes aim to strengthen technology transfer in order to benefit society.
IRB Barcelona and the BSC show their commitment to computational biology by renewing the Joint IRB-BSC Programme, which also doubles in the number of researchers involved.
The programme aims to position itself as an international leader in computational biology.
The new data base, which includes 1,700 proteins in motion, allows a more efficient design of drugs.
MoDEL holds 30% of human therapeutic targets and the objective is to cover 80% in three years.
The prediction of the structure and function of biological macromolecules (i.e., the machinery of life) is of foremost importance in the field of structural biology.
The scientific journalist Pere Estupinyà has written an entertaining account in his blog in the newspaper El País “Science notes from MIT” about five researchers that he met during a visit he made to IRB Barcelona in May.
Read the article (in Spanish):
This is a key process to understand gene activity and DNA replication, and to design drugs to modulate them in the future.
Modesto Orozco receives the Bruker Prize and Pau Bernadó the I Prize for Young Investigators.